UTRN as a potential biomarker in breast cancer: a comprehensive bioinformatics and in vitro study

Han Li(Wuhan University), Peng Yang(Chinese Academy of Sciences), Zehao Cai(Capital Medical University), Wenhao Tan(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dongyao Pu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dan Shu(The Ohio State University), Meiying Shen, Wenjie Zhang(Shanghai Jiao Tong University), Kang Li(Sun Yat-sen University), Yang Liu, Ailin Lan(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Scientific Reports
April 2, 2024
10.1038/s41598-024-58124-5
Cited by 4

Related Papers

An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
|The International Journal of Neuropsychopharmacology|2011|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
Lactate Elicits ER-Mitochondrial Mg2+ Dynamics to Integrate Cellular Metabolism
|Cell|2020|218
Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression
|Cancer Communications|2022|203